Administrative Core

行政核心

基本信息

  • 批准号:
    10225447
  • 负责人:
  • 金额:
    $ 11.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-15 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2) is an integrated program of epidemiologists, otolaryngologists, allergists and immunologists in which highly collaborative studies are proposed to better understand the molecular and cellular mechanisms of disease heterogeneity and how these mechanisms translate into clinical phenotypes, natural history and long term outcomes. The program focuses particular attention to CRS without nasal polyps (CRSsNP), a highly prevalent and yet obscure phenotype from the standpoint of our current understanding. Another focus of CRISP2 is to critically evaluate the mechanisms and consequences of comorbid conditions in which patients have both CRS and lung disease such as asthma or bronchiectasis. Yet another theme is to make inroads in our understanding of why women are more significantly impacted by CRS than men. In order to achieve these goals, the investigators that comprise the CRISP2 study team have innovated new assays and approaches to cutting edge studies of pathogenesis and epidemiology and, most importantly, have merged these two disciplines to relate mechanisms to symptoms, severity, history and outcomes of CRS. The Administrative Core (Core A) has as its main functions the goals of providing administrative support for the vigorous integrative efforts of the program, facilitating communication and data sharing, catalyzing publications and reporting of the findings of the work, ensuring that the Chronic Rhinosinusitis Integrative Research Program-2 (CRISP2) promotes an effective training function and organizing the advisory board and the regular meetings of the CRISP2 participating centers and investigators. Core A is also responsible for the preparation of progress reports for the program and overseeing regulatory compliance with various institutional and governmental agencies. Core A will play a central role in promoting synergy and advanced collaborative interactions in the program. We have organized these and other functions into the following specific aims: 1.) To provide central administrative services for CRISP2, including oversight of funds distribution, managing the administrative office, facilitating changes that occur in budget, personnel or scientific direction, overseeing preparation of progress reports and assurance of appropriate compliance with directives from the NIH, NU, UC, G/JHU and local, state and federal agencies. The administrative team is Dr. Schleimer (PI), Ms. Valarie Thomas and Ms. Seletta Nichols (administrators) and Dr. Alfred Rademaker (biostatistician). 2.) To facilitate communications in CRISP2 and organize an advisory board. CRISP2 will have four quarterly meetings each year and will maintain an internet-based cloud communications system. 3.) To disseminate discoveries made by CRISP2. Core A will facilitate manuscript preparation and maintenance of a website. 4.) To encourage training. Core A will support an ongoing grant program for young scholars. 5.) To promote interdisciplinary research. Core A will facilitate interactions of the disciplines and individual investigators that are involved in CRISP2.
慢性鼻窦炎综合研究项目2(CRISP 2)是一个综合项目, 流行病学家、耳鼻喉科医生、过敏症专家和免疫学家进行了高度合作的研究 提出更好地了解疾病异质性的分子和细胞机制,以及这些机制如何影响疾病的发生。 机制转化为临床表型、自然史和长期结果。该计划侧重 特别注意无鼻息肉的CRS(CRSsNP),这是一种高度流行但尚不清楚的表型, 我们目前的理解。CRISP 2的另一个重点是批判性地评估 以及患者同时患有CRS和肺部疾病(如哮喘)的共病状况的后果 或支气管扩张。另一个主题是让我们更好地理解为什么女性比男性 对CRS的影响比男性更大。为了实现这些目标,调查人员组成的 CRISP 2研究团队已经创新了新的检测方法和方法,以进行发病机制的前沿研究, 流行病学,最重要的是,合并了这两个学科,将机制与症状联系起来, CRS的严重程度、病史和结局。 行政核心(核心A)的主要职能是提供行政支助 对于该计划的积极综合努力,促进沟通和数据共享,催化 出版物和工作结果的报告,确保慢性鼻窦炎综合治疗 研究计划-2(CRISP 2)促进有效的培训职能和组织咨询委员会, CRISP 2参与中心和研究者的定期会议。核心A还负责 为该计划准备进度报告,并监督各机构的监管合规性 和政府机构。核心A将在促进协同和高级协作方面发挥核心作用 节目中的互动。我们将这些职能和其他职能组织成以下具体目标:1. 为CRISP 2提供中央行政服务,包括监督资金分配、管理 行政办公室,促进预算,人事或科学方向发生的变化,监督 准备进度报告,并确保适当遵守NIH、NU、UC的指令, G/JHU和地方、州和联邦机构。管理团队为Schleimer博士(PI)、Valarie托马斯女士 以及Seletta Nichols女士(管理员)和Alfred Rademaker博士(生物统计学家)。2.)的情况。以促进 CRISP 2中的通信,并组织一个咨询委员会。CRISP 2将每季度举行四次会议, 2015年,将继续使用云通信系统。3.)第三章传播科学家的发现 CRISP2.核心项目A将协助编写文稿和维护网站。4.)鼓励培训。 核心A将支持一个正在进行的年轻学者赠款计划。5.)促进跨学科研究。 核心A将促进参与CRISP 2的学科和个体研究者之间的互动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert P Schleimer其他文献

Aberrant TFR cells associate with immunoglobulin hyperproduction in nasal polyps with ectopic lymphoid tissues
  • DOI:
    https://doi.org/10.1016/j.jaci.2023.11.91.
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
  • 作者:
    Jia Song;Hai Wang;Zhe-Zheng Wang;Cui-Lian Guo;Wen-Xuan Xiang;Jing-Xian Li;Zhi-Chao Wang;Ji-Xin Zhong;Kun Huang;Robert P Schleimer;Yin Yao;Zheng Liu
  • 通讯作者:
    Zheng Liu

Robert P Schleimer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert P Schleimer', 18)}}的其他基金

Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
CRS中屏障功能障碍和组织增生的机制
  • 批准号:
    10458540
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
CRS中屏障功能障碍和组织增生的机制
  • 批准号:
    10897481
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2)
慢性鼻窦炎综合研究计划 2 (CRISP2)
  • 批准号:
    10225446
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2)
慢性鼻窦炎综合研究计划 2 (CRISP2)
  • 批准号:
    10671609
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
CRS中屏障功能障碍和组织增生的机制
  • 批准号:
    10225449
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2)
慢性鼻窦炎综合研究计划 2 (CRISP2)
  • 批准号:
    10458536
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Population-based CRS epidemiology: sex differences, natural history, and long-term outcomes based on clinically-defined phenotypes and biologically-based endotypes - Geisinger
基于人群的 CRS 流行病学:基于临床定义的表型和生物学内型的性别差异、自然史和长期结果 - Geisinger
  • 批准号:
    10458542
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Population-based CRS epidemiology: sex differences, natural history, and long-term outcomes based on clinically-defined phenotypes and biologically-based endotypes - Geisinger
基于人群的 CRS 流行病学:基于临床定义的表型和生物学内型的性别差异、自然史和长期结果 - Geisinger
  • 批准号:
    10225451
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Population-based CRS epidemiology: sex differences, natural history, and long-term outcomes based on clinically-defined phenotypes and biologically-based endotypes - Geisinger
基于人群的 CRS 流行病学:基于临床定义的表型和生物学内型的性别差异、自然史和长期结果 - Geisinger
  • 批准号:
    10897483
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10897479
  • 财政年份:
    2019
  • 资助金额:
    $ 11.36万
  • 项目类别:

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 11.36万
  • 项目类别:
    Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
    Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
    Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
  • 批准号:
    10723233
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
  • 批准号:
    10723861
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
  • 批准号:
    10586398
  • 财政年份:
    2023
  • 资助金额:
    $ 11.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了